Obstructive Sleep Apnea (OSA)
Treating Obstructive Sleep Apnea Through Weight Management
How Leango supports better breathing and deeper sleep in adults with obesity
Obstructive Sleep Apnea (OSA) is a serious disorder in which breathing repeatedly stops and starts during sleep. In many cases, excess tissue around the neck due to obesity blocks the airway. Leango, as the first and only GIP and GLP-1 receptor agonist, is approved not only for weight management but also as a treatment for moderate to severe OSA in adults with obesity.
Why Weight Loss is Key to Treating OSA
Fat accumulation around the upper respiratory tract narrows the airways, leading to severe snoring and shortness of breath. Leango helps improve these conditions through the following mechanisms:
Fat reduction around the neck:
By reducing overall body weight, pressure on the airways decreases, facilitating nighttime breathing.
Improved respiratory metrics:
Studies show that weight management with tirzepatide can significantly reduce the apnea-hypopnea index (AHI)—the number of breathing interruptions per hour.
Increased daytime energy:
Better sleep quality reduces fatigue and excessive daytime sleepiness.
Safety and Care Considerations
During the course of sleep apnea treatment with Leango, it is essential to pay attention to the following:
Continued use of complementary treatments:
Leango does not replace CPAP or other physician-recommended therapies, but acts as a complementary treatment addressing the root cause (obesity).
Monitoring by specialists:
If you have a history of severe respiratory problems, coordinate your treatment with a pulmonologist or sleep specialist.
Report changes promptly:
Any issues with swallowing, voice changes, or neck masses should be reported to your doctor immediately.
Starting Your Journey to Restful Sleep
If your BMI is over 30 kg/m² and you experience sleep disturbances, Leango may be a suitable treatment option. The usual starting dose is 2.5 mg per week, designed to minimize gastrointestinal side effects and gradually increased under medical supervision.
Questions and Answers
Leango aims to reduce the severity of the disease through weight management, but discontinuing CPAP use should only be done under the advice of a specialist and after a sleep test (polysomnography) is repeated.
Even moderate weight loss can significantly relieve pressure on the airways and reduce the number of times you wake up at night.
No. Leango does not directly cause sleepiness, but by improving nighttime sleep quality, it enhances daytime alertness.